Intrahepatic Cholangiocarcinoma

general

A carcinoma that arises from the intrahepatic bile duct epithelium in any site of the intrahepatic biliary tree. Grossly, the malignant lesions are solid, nodular, and grayish. Morphologically, the vast majority of cases are adenocarcinomas. Signs and symptoms include malaise, weight loss, right upper quadrant abdominal pain, and night sweats. Early detection is difficult and the prognosis is generally poor.

76

Centers

161

Active Trials

$2.4B

Cancer Funding

Specific Cancer Types(3)

Top Centers for Intrahepatic Cholangiocarcinoma(76)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
High-Volume Research Center
81.8
2
NCI Comprehensive
Active Research Program
69.3
3
NCI Comprehensive
Active Research Program
68.9
4
NCI Comprehensive
Active Research Program
68.4
5
NCI Comprehensive
Active Research Program
68.4
6
NCI Comprehensive
Active Research Program
68.4
7
NCI Comprehensive
Active Research Program
67.9
8
NCI Comprehensive
Active Research Program
66.4
9
NCI Comprehensive
Active Research Program
66.1
10
NCI Comprehensive
Active Research Program
66.1
11
NCI Comprehensive
Active Research Program
66.1
12
Active Research Program
66.1
13
NCI Comprehensive
Active Research Program
65.9
14
NCI Comprehensive
Active Research Program
64.9
15
NCI Comprehensive
Active Research Program
64.4
16
NCI Comprehensive
Active Research Program
63.4
17
NCI Comprehensive
Active Research Program
48.2
18
NCI Comprehensive
Active Research Program
48.2
19
NCI Comprehensive
Active Research Program
48.2
20
NCI Comprehensive
Active Research Program
48.2
21
NCI Comprehensive
Active Research Program
48.2
22
NCI Comprehensive
Active Research Program
48.2
23
NCI Comprehensive
Active Research Program
48.2
24
NCI Comprehensive
Active Research Program
48.2
2548.2
26
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
48.2
27
NCI Comprehensive
Active Research Program
48.2
28
NCI Comprehensive
Active Research Program
48.2
29
NCI Comprehensive
Active Research Program
48.2
30
NCI Clinical
Active Research Program
48.2
31
NCI Comprehensive
Active Research Program
48.2
32
NCI Comprehensive
Active Research Program
48.2
33
NCI Comprehensive
Active Research Program
48.2
34
NCI Comprehensive
Active Research Program
48.2
35
NCI Clinical
Active Research Program
48.2
36
Active Research Program
48.2
37
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
48.2
38
NCI Comprehensive
Active Research Program
48.2
39
Active Research Program
48.2
40
NCI Clinical
Active Research Program
48.2
41
NCI Comprehensive
Active Research Program
48.2
42
Active Research Program
48.2
43
NCI Clinical
Active Research Program
48.2
44
NCI Comprehensive
Active Research Program
48.2
45
Active Research Program
48.2
46
Active Research Program
48.2
4748.2
48
Active Research Program
48.2
49
Active Research Program
48.2
50
NCI Basic_laboratory
Active Research Program
48.2
51
Active Research Program
48.2
52
Active Research Program
48.2
53
Active Research Program
48.2
54
Active Research Program
48.2
55
Active Research Program
48.2
56
Active Research Program
48.2
57
Active Research Program
48.2
58
Active Research Program
48.2
59
NCI Comprehensive
Active Research Program
47.5
60
NCI Comprehensive
Active Research Program
47.0
61
NCI Basic_laboratory
Active Research Program
45.5
62
NCI Comprehensive
Active Research Program
43.0
63
NCI Comprehensive
Active Research Program
42.5
64
NCI Comprehensive
28.3
6528.3
66
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
28.3
67
NCI Comprehensive
28.3
6828.3
6928.3
70
NCI Comprehensive
71
NCI Comprehensive
72
73
NCI Comprehensive
74
75
76
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →